radical cystectomy The American Society of Clinical Oncology (ASCO) endorsed the European Association of Urology's guideline on
muscle-invasive bladder cancer (MIBC) and metastatic bladder cancer and has added qualifying statements, according to a statement published in the
Journal of Clinical Oncology.
1
“The standard treatment of MIBC is neoadjuvant cisplatin-based combination chemotherapy followed by radical cystectomy,” the authors concluded. https://www.cancertherapyadvisor.com/urologic-cancers/bladder-cancer-asco-eau-guideline-endorsement/article/487904/
All is well...